- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05734586
Screening for Sarcopenic Dysphagia and the Implementation of Measures to Prevent Its Complications in Geriatric Patients [DYSPHAGING-PILOT] (DYSPHAGING-P)
Feasibility Study of Screening for Sarcopenic Dysphagia and the Implementation of Measures to Prevent Its Complications in Geriatric or Institutionalized Patients Aged ≥ 70 Years.
Sarcopenic dysphagia is described as a swallowing disorder caused by a loss of muscle mass and strength, sarcopenia. It induces chronic complications like micro-inhalations and the worsening of chronic undernutrition, according to a vicious circle. Awareness of the high prevalence of sarcopenic dysphagia and its serious consequences among elderly people with disabilities and hospitalized patients is recent, which explains the low rate of screening in the population concerned. In this context, methods of prevention, evaluation and intervention of sarcopenic dysphagia adapted to the most exposed population are needed.
Two European learned societies have developed recommendations that include increased awareness of swallowing disorders, the use of screening scores, preventive measures, diagnostic standardization, and implemented interventions (rehabilitation, textural adaptation, etc.). In order to respect these recommendations, a pedagogical sheet, entitled DYSPHAGING was elaborated within our unit in a multiprofessional way in 4 steps (1 - Screen; 2 - Protect; 3 - Confirm; 4 - Rehabilitate).
This feasibility study aims to evaluate the rate of completion and the conditions for implementing steps 1 and 2 in hospital and institutional care units.
Study Overview
Status
Conditions
Detailed Description
Sarcopenic dysphagia is described as a swallowing disorder caused by a loss of muscle mass and strength, sarcopenia. It induces chronic complications like micro-inhalations and the worsening of chronic undernutrition, according to a vicious circle. Awareness of the high prevalence of sarcopenic dysphagia and its serious consequences among elderly people with disabilities and hospitalized patients is recent, which explains the low rate of screening in the population concerned. In this context, methods of prevention, evaluation and intervention of sarcopenic dysphagia adapted to the most exposed population are needed.
Two European learned societies have developed recommendations that include increased awareness of swallowing disorders, the use of screening scores, preventive measures, diagnostic standardization, and implemented interventions (rehabilitation, textural adaptation, etc.). In order to respect these recommendations, a pedagogical sheet, entitled DYSPHAGING was elaborated within our unit in a multiprofessional way in 4 steps (1 - Screen; 2 - Protect; 3 - Confirm; 4 - Rehabilitate).
This feasibility study aims to evaluate the rate of completion and the conditions for implementing steps 1 and 2 in hospital and institutional care units.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marion MERDINIAN, Dr
- Phone Number: 00 33 4 78 86 56 83
- Email: marion.merdinian@chu-lyon.fr
Study Contact Backup
- Name: Claire FALANDRY, Pr
- Phone Number: 00 33 4 78 86 66 34
- Email: claire.falandry@chu-lyon.fr
Study Locations
-
-
-
Lyon, France, 69495
- Recruiting
- Centre Hospitalier Lyon Sud - Court Séjour Gériatrique
-
Contact:
- Marion MERDINIAN, Dr
- Phone Number: 00 33 4 78 86 56 83
- Email: marion.merdinian@chu-lyon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient aged ≥ 70 years,
- Patient affiliated to a social security system,
- Patient hospitalized in the health sector or in a medico-social institute,
- Patient informed of the study (information leaflet provided) and having orally signified their consent to inclusion in the study.
- Patient under legal protection, guardianship or curatorship,
Exclusion Criteria:
- Patient unable to feed orally,
- Patient with an active pathology responsible for acute swallowing disorders (< 3 months) (neurodegenerative pathology with predominant motor impairment such as Charcot's disease, stroke, ENT disease).
- Patient unable to answer the questionnaire.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: DYSPHAGING Interventional group
Patient characteristics will be collected at each site at the end of the study by a clinical research assistant based on their medical records. At the end of the study, each allied health professionals who has been involved in the care of at least one patient will fill out a satisfaction questionnaire. |
After inclusion, issuance of the EAT-10 screening questionnaire for swallowing disorders by the healthcare team
In the event of an EAT ≥2 score, immediate implementation or within three days by the healthcare team of protective measures for the upper airways in 3 sectors: 1: Postural maneuvers; 2: Hygienodietetic rules; 3: Food textures |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of complete achievement of steps 1 and 2
Time Frame: Three days
|
The judgment criterion is validated if
|
Three days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of eligible patients refusing to participate in the study
Time Frame: 18 months
|
Number of eligible patients who refused to participate in the study
|
18 months
|
Age, gender, comorbidities (CIRS-G), autonomy (ADL, IADL), co-medications
Time Frame: 19 months
|
Patient characteristics will be collected at each site at the end of the study by a clinical research assistant based on their medical records.
|
19 months
|
Rate of partial completion of the protocol
Time Frame: 19 months
|
Proportion of non-performance of step 1 and/or step 2 within the time limit.
Proportion of steps 2 carried out incompletely), description of the reasons
|
19 months
|
Diagnosis of undernutrition and/or neurocognitive disorders and/or patent lung infection and/or COPD described in the patient's medical file, nutritional risk situation assessed by the Mini Nutritional Assessment® (MNA)
Time Frame: 19 months
|
Patient characteristics will be collected at each site at the end of the study by a clinical research assistant based on their medical records.
|
19 months
|
Composition and disciplines of the care team
Time Frame: 19 months
|
At the end of the study, all data on the each allied health professionals will be collected on the dysphaging sheet
|
19 months
|
Caregiver satisfaction (Likert scale).
Time Frame: 19 months
|
At the end of the study, each allied health professionals who has been involved in the care of at least one patient will fill out a satisfaction questionnaire.
|
19 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL22_0474
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Swallowing Disorder
-
Hacettepe UniversityCompletedSwallowing DisorderTurkey
-
National Taiwan University HospitalCompletedSwallowing DisorderTaiwan
-
Showa Inan General HospitalCompleted
-
University of ManchesterCompletedDysphagia | Swallowing DisorderUnited Kingdom
-
University of ManchesterCompleted
-
Hacettepe UniversityCompletedChewing Problem | Swallowing DisorderTurkey
-
University Hospital, ToulouseFondation de l'AvenirCompletedSwallowing DisordersFrance
-
University of HaifaCompletedHealthy Aging | Gender | Swallowing Disorder
Clinical Trials on EAT-10 (Eating assessment Tool) screening questionnaire
-
University of FloridaCompleted
-
Hospices Civils de LyonNot yet recruitingAnorexia NervosaFrance
-
Great Ormond Street Hospital for Children NHS Foundation...WithdrawnDisordered EatingUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; The New School for Social Research and other collaboratorsActive, not recruitingAdvanced CancerUnited States
-
National Taiwan University HospitalNot yet recruitingUpper Esophageal Sphincter Relaxing Pressure
-
Netherlands Open UniversityMaastricht University Medical Center; Dutch Cancer Society; Maastro Clinic, The... and other collaboratorsCompletedBreast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Non-Hodgkin Lymphoma | Bladder Cancer | Cervix Cancer | Cancer of Skin | Cancer of EndometriumNetherlands
-
University of FloridaCompletedCommunity-dwelling Older AdultsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphedema | Ovarian Cancer | Vaginal Cancer | Uterine CancerUnited States
-
University of MiamiNot yet recruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States, Peru